F Bravi1, J Polesel2, C Bosetti3, R Talamini2, E Negri3, L Dal Maso4, D Serraino2, C La Vecchia5. 1. Department of Epidemiology, Mario Negri Institute for Pharmacological Research, Milan; Department of Occupational Medicine 'Luigi Devoto Work Clinic', Section of Medical Statistics and Biometry 'Giulio A. Maccacaro', University of Milan, Milan. Electronic address: francesca.bravi@marionegri.it. 2. Unit of Epidemiology and Biostatistics, Centro di Riferimento Oncologico, Aviano (PN), Italy. 3. Department of Epidemiology, Mario Negri Institute for Pharmacological Research, Milan. 4. Department of Occupational Medicine 'Luigi Devoto Work Clinic', Section of Medical Statistics and Biometry 'Giulio A. Maccacaro', University of Milan, Milan; Unit of Epidemiology and Biostatistics, Centro di Riferimento Oncologico, Aviano (PN), Italy. 5. Department of Epidemiology, Mario Negri Institute for Pharmacological Research, Milan; Department of Occupational Medicine 'Luigi Devoto Work Clinic', Section of Medical Statistics and Biometry 'Giulio A. Maccacaro', University of Milan, Milan.
Abstract
OBJECTIVE: several studies have shown an inverse relation between vegetable and fruit intake and pancreatic cancer, but no specific beneficial component of such foods has been consistently identified. We considered the role of 15 selected vitamins and carotenoids and 6 minerals on pancreatic cancer risk in an Italian case-control study. METHODS: subjects were 326 patients with incident pancreatic cancer and 652 controls, admitted to the same hospitals as cases for acute conditions. Micronutrient computation was based on a validated and reproducible food-frequency questionnaire. We estimated the odds ratios (OR) and confidence intervals (CI) using conditional logistic regression models, adjusted for various confounding factors and for energy intake, according to the residual model. RESULTS: comparing the highest to the lowest quintile of intake, the OR were 0.60 (95% CI 0.36-0.98) for vitamin E, 0.44 (95% CI 0.27-0.73) for vitamin C, 0.56 (95% CI 0.34-0.93) for folate, and 0.57 (95% CI 0.35-0.92) for potassium. No significant inverse associations were observed for α-carotene (OR = 0.69, 95% CI 0.43-1.12), β-carotene (OR = 0.64, 95% CI 0.39-1.06), and β-cryptoxanthin (OR = 0.66, 95% CI 0.39-1.09). No relation was found for other micronutrients considered. CONCLUSION: our findings support a favorable role of vitamins E and C, selected carotenoids, and folate on pancreatic carcinogenesis.
OBJECTIVE: several studies have shown an inverse relation between vegetable and fruit intake and pancreatic cancer, but no specific beneficial component of such foods has been consistently identified. We considered the role of 15 selected vitamins and carotenoids and 6 minerals on pancreatic cancer risk in an Italian case-control study. METHODS: subjects were 326 patients with incident pancreatic cancer and 652 controls, admitted to the same hospitals as cases for acute conditions. Micronutrient computation was based on a validated and reproducible food-frequency questionnaire. We estimated the odds ratios (OR) and confidence intervals (CI) using conditional logistic regression models, adjusted for various confounding factors and for energy intake, according to the residual model. RESULTS: comparing the highest to the lowest quintile of intake, the OR were 0.60 (95% CI 0.36-0.98) for vitamin E, 0.44 (95% CI 0.27-0.73) for vitamin C, 0.56 (95% CI 0.34-0.93) for folate, and 0.57 (95% CI 0.35-0.92) for potassium. No significant inverse associations were observed for α-carotene (OR = 0.69, 95% CI 0.43-1.12), β-carotene (OR = 0.64, 95% CI 0.39-1.06), and β-cryptoxanthin (OR = 0.66, 95% CI 0.39-1.09). No relation was found for other micronutrients considered. CONCLUSION: our findings support a favorable role of vitamins E and C, selected carotenoids, and folate on pancreatic carcinogenesis.
Authors: M Waterhouse; H A Risch; C Bosetti; K E Anderson; G M Petersen; W R Bamlet; M Cotterchio; S P Cleary; T I Ibiebele; C La Vecchia; H G Skinner; L Strayer; P M Bracci; P Maisonneuve; H B Bueno-de-Mesquita; W Zaton Ski; L Lu; H Yu; K Janik-Koncewicz; J Polesel; D Serraino; R E Neale Journal: Ann Oncol Date: 2015-05-14 Impact factor: 32.976
Authors: J M Genkinger; M Wang; R Li; D Albanes; K E Anderson; L Bernstein; P A van den Brandt; D R English; J L Freudenheim; C S Fuchs; S M Gapstur; G G Giles; R A Goldbohm; N Håkansson; P L Horn-Ross; A Koushik; J R Marshall; M L McCullough; A B Miller; K Robien; T E Rohan; C Schairer; D T Silverman; R Z Stolzenberg-Solomon; J Virtamo; W C Willett; A Wolk; R G Ziegler; S A Smith-Warner Journal: Ann Oncol Date: 2014-03-14 Impact factor: 32.976
Authors: Samuel O Antwi; William R Bamlet; Katrina S Pedersen; Kari G Chaffee; Harvey A Risch; Nitin Shivappa; Susan E Steck; Kristin E Anderson; Paige M Bracci; Jerry Polesel; Diego Serraino; Carlo La Vecchia; Cristina Bosetti; Donghui Li; Ann L Oberg; Alan A Arslan; Demetrius Albanes; Eric J Duell; Inge Huybrechts; Laufey T Amundadottir; Robert Hoover; Satu Mannisto; Stephen J Chanock; Wei Zheng; Xiao-Ou Shu; Magdalena Stepien; Federico Canzian; Bas Bueno-de-Mesquita; José Ramon Quirós; Anne Zeleniuch-Jacquotte; Fiona Bruinsma; Roger L Milne; Graham G Giles; James R Hébert; Rachael Z Stolzenberg-Solomon; Gloria M Petersen Journal: Carcinogenesis Date: 2018-07-30 Impact factor: 4.944
Authors: Xuesong Han; Jingjing Li; Theodore M Brasky; Pengcheng Xun; June Stevens; Emily White; Marilie D Gammon; Ka He Journal: Cancer Date: 2012-12-21 Impact factor: 6.860